RYTM Latest Headlines

Key deals this week: PANW, META, OGI, CRM and more

at seekingalpha.com (Sat, 7-Nov 3:15 PM)

Rhythm Pharmaceuticals gains on report of additional bidder

at seekingalpha.com (Fri, 6-Nov 11:06 AM)

Rhythm Pharmaceuticals’ Strong Imcivree Launch and Pipeline Progress Support $130 Price Target

at www.tipranks.com (Fri, 6-Nov 2:16 AM)

Rhythm Pharmaceuticals (RYTM) Receives a Rating Update from a Top Analyst

at www.tipranks.com (Thu, 5-Nov 7:16 AM)

Analysts Offer Insights on Healthcare Companies: Opko Health (OPK) and Rhythm Pharmaceuticals (RYTM)

at www.tipranks.com (Thu, 5-Nov 6:50 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Alpha Teknova (TKNO) and Lemaitre Vascular (LMAT)

at www.tipranks.com (Thu, 5-Nov 3:50 AM)

Rhythm Pharmaceuticals Faces Heightened Liquidity Risk Under Restrictive KKR and Blackstone Term-Loan Covenants

at www.tipranks.com (Thu, 5-Nov 1:00 AM)

RYTM Rallies After NICE Expands IMCIVREE Reimbursement to Adults With Bardet-Biedl Syndrome

Market Chameleon (Wed, 4-Nov 11:17 AM)

Rhythm Pharmaceuticals highlights 700+ IMCIVREE start forms as quarterly product revenue reaches $92.10 million

Market Chameleon (Tue, 3-Nov 7:40 AM)